Prestige Biologics Co (XKRX:334970) 3-Year EBITDA Growth Rate : -13.60% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Prestige Biologics Co 3-Year EBITDA Growth Rate?

Prestige Biologics Co's EBITDA per Share for the three months ended in Mar. 2024 was ₩-152.55.

During the past 3 years, the average EBITDA Per Share Growth Rate was -13.60% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -0.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 7 years, the highest 3-Year average EBITDA Per Share Growth Rate of Prestige Biologics Co was 9.80% per year. The lowest was -58.00% per year. And the median was -8.25% per year.

Competitive Comparison of Prestige Biologics Co's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Prestige Biologics Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Prestige Biologics Co's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Prestige Biologics Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Prestige Biologics Co's 3-Year EBITDA Growth Rate falls into.

Prestige Biologics Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Prestige Biologics Co (XKRX:334970) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Prestige Biologics Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Prestige Biologics Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Prestige Biologics Co (XKRX:334970) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Prestige Biologics Co Ltd (XKRX:334970) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

197, Osongsaengmyeong 1-ro, Osong-eup, Heungdeok-gu, Chungcheongbuk-do, Cheongju-si, KOR, 28161

Website

https://www.prestigebiologics.com

Prestige Biologics Co Ltd is a CDMO-dedicated company that provides solutions of development and manufacturing tasks throughout the stages from the research/development, engineering, clinical production, commercial production, clinical support, and IND & BLA filing of biopharmaceutical products. Its product candidate includes HD201 (Herceptin Biosimilar).

Prestige Biologics Co (XKRX:334970) Headlines

No Headlines